|
FR2097737A5
(en)
|
1970-07-14 |
1972-03-03 |
Berlin Chemie Veb |
Virustatic 4-substd 1-acylthiosemicarbazides -from carboxylic acid - hydrazide and isothiocyanates or from carboxylic acid chloride and 4-
|
|
DE2037257A1
(en)
|
1970-07-28 |
1972-02-03 |
Farbwerke Hoechst AG, vorm. Meister Lucius & Brüning, 6000 Frankfurt |
Poly-(5-amino-1,3,4-thiadiazol-2-yl) derivs prepn - intermediates for drug and polymer prodn
|
|
GB1272920A
(en)
|
1971-03-15 |
1972-05-03 |
Berlin Chemie Veb |
New thiosemicarbazides
|
|
US4012360A
(en)
|
1973-12-03 |
1977-03-15 |
Ciba-Geigy Corporation |
Bis-salicyloyl-dicarboxylic acid dihydrazides as stabilizers for polyolefines
|
|
JPS5091056A
(US06894165-20050517-C00155.png)
|
1973-12-17 |
1975-07-21 |
|
|
|
US4822777A
(en)
|
1987-02-27 |
1989-04-18 |
Liposome Technology, Inc. |
Amphotericin B/cholesterol sulfate composition
|
|
JP2767241B2
(ja)
*
|
1987-04-15 |
1998-06-18 |
ロ−ム アンド ハ−ス コンパニ− |
殺虫性のｎ−（場合により置換された）−ｎ′−置換−ｎ，ｎ′−ジ置換ヒドラジン
|
|
US6013836A
(en)
|
1992-02-28 |
2000-01-11 |
Rohm And Haas Company |
Insecticidal N'-substituted-N,N'-disubstitutedhydrazines
|
|
FR2697752B1
(fr)
|
1992-11-10 |
1995-04-14 |
Rhone Poulenc Rorer Sa |
Compositions antitumorales contenant des dérivés du taxane.
|
|
EP0693924B2
(en)
|
1993-02-22 |
2008-04-09 |
Abraxis BioScience, Inc. |
Methods for (in vivo) delivery of biologics and compositions useful therefor
|
|
US5916596A
(en)
|
1993-02-22 |
1999-06-29 |
Vivorx Pharmaceuticals, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
US6753006B1
(en)
|
1993-02-22 |
2004-06-22 |
American Bioscience, Inc. |
Paclitaxel-containing formulations
|
|
US6096331A
(en)
|
1993-02-22 |
2000-08-01 |
Vivorx Pharmaceuticals, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
|
US5439686A
(en)
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
|
US6537579B1
(en)
|
1993-02-22 |
2003-03-25 |
American Bioscience, Inc. |
Compositions and methods for administration of pharmacologically active compounds
|
|
US6749868B1
(en)
|
1993-02-22 |
2004-06-15 |
American Bioscience, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
US5665382A
(en)
|
1993-02-22 |
1997-09-09 |
Vivorx Pharmaceuticals, Inc. |
Methods for the preparation of pharmaceutically active agents for in vivo delivery
|
|
US5840746A
(en)
|
1993-06-24 |
1998-11-24 |
Merck Frosst Canada, Inc. |
Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases
|
|
US5523325A
(en)
*
|
1993-09-09 |
1996-06-04 |
Jacobson; Richard M. |
Amidrazones and their use as pesticides
|
|
WO1995033710A1
(de)
*
|
1994-06-03 |
1995-12-14 |
Basf Aktiengesellschaft |
Carbamoylcarbonsäurehydrazide und ihre verwendung zur bekämpfung von schadpilzen
|
|
DE69604298T2
(de)
|
1995-09-22 |
2000-05-18 |
Bioimage A/S, Soeborg |
Varianten des grünen fluoreszenzproteins, gfp
|
|
US5739686A
(en)
|
1996-04-30 |
1998-04-14 |
Naughton; Michael J. |
Electrically insulating cantilever magnetometer with mutually isolated and integrated thermometry, background elimination and null detection
|
|
US6235787B1
(en)
|
1997-06-30 |
2001-05-22 |
Hoffmann-La Roche Inc. |
Hydrazine derivatives
|
|
GB9727524D0
(en)
|
1997-12-31 |
1998-02-25 |
Pharmacia & Upjohn Spa |
Synergistic antitumor composition containing a biologically active ureido compound
|
|
TW479053B
(en)
|
1998-10-19 |
2002-03-11 |
Agro Kanesho Co Ltd |
Hydrazineoxoacetamide derivatives and pesticides
|
|
ES2161594B1
(es)
|
1998-12-17 |
2003-04-01 |
Servier Lab |
Nuevos derivados de la hidrazida, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
|
|
US6322303B1
(en)
|
2000-05-12 |
2001-11-27 |
David M. John |
Dunnage bag and method of making same
|
|
EP1164126A1
(de)
|
2000-06-16 |
2001-12-19 |
Basf Aktiengesellschaft |
Salicylsäurehydrazid-Derivate, Verfahren und Zwischenprodukte zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung zur Bekämpfung von Schadpilzen
|
|
US6365745B1
(en)
|
2000-07-14 |
2002-04-02 |
Sumika Fine Chemicals Co., Ltd. |
Method for producing hydrazine derivative
|
|
MXPA03006666A
(es)
|
2001-01-25 |
2004-05-31 |
Guilford Pharm Inc |
Compuestos de union de ciclofilina carbociclicos trisubstituidos y su uso.
|
|
CA2445967A1
(en)
*
|
2001-05-01 |
2002-11-07 |
Abbott Laboratories |
Compositions comprising lopinavir and methods for enhancing the bioavailability of pharmaceutical agents
|
|
WO2002094259A1
(en)
|
2001-05-03 |
2002-11-28 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Compounds that inhibit hsp90 and stimulate hsp70 and hsp40, useful in the prevention or treatment of diseases associated with protein aggregation and amyloid formation
|
|
US6602907B1
(en)
|
2001-06-08 |
2003-08-05 |
University Of Central Florida |
Treatment of breast cancer
|
|
US6924312B2
(en)
|
2001-07-10 |
2005-08-02 |
Synta Pharmaceuticals Corp. |
Taxol enhancer compounds
|
|
TWI332943B
(en)
|
2001-07-10 |
2010-11-11 |
Synta Pharmaceuticals Corp |
Taxol enhancer compounds
|
|
TWI252847B
(en)
*
|
2001-07-10 |
2006-04-11 |
Synta Pharmaceuticals Corp |
Synthesis of taxol enhancers
|
|
TWI297335B
(en)
*
|
2001-07-10 |
2008-06-01 |
Synta Pharmaceuticals Corp |
Taxol enhancer compounds
|
|
US20050154039A1
(en)
|
2001-11-28 |
2005-07-14 |
Marie-Odile Glacera Contour |
5-Sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
|
|
TW200408407A
(en)
|
2001-11-30 |
2004-06-01 |
Dana Farber Cancer Inst Inc |
Methods and compositions for modulating the immune system and uses thereof
|
|
AU2006228035B2
(en)
|
2003-01-15 |
2010-02-18 |
Synta Pharmaceuticals Corp. |
Bis (thio-hydrazide amide) compounds for treating multi-drug resistant cancer
|
|
JP4921162B2
(ja)
|
2003-02-11 |
2012-04-25 |
ヴァーナリス（ケンブリッジ）リミテッド |
熱ショックタンパク質の阻害剤としてのイソオキサゾール化合物類
|
|
KR100575251B1
(ko)
|
2003-03-03 |
2006-05-02 |
재단법인서울대학교산학협력재단 |
ｐ38／ＪＴＶ－1을 유효성분으로 하는 암 치료용 약학적조성물 및 암 치료용 약학적 조성물의 스크리닝 방법
|
|
EP1493445A1
(en)
|
2003-07-04 |
2005-01-05 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Inhibition of stress-induced ligand-dependent EGFR activation
|
|
AR045595A1
(es)
|
2003-09-04 |
2005-11-02 |
Vertex Pharma |
Composiciones utiles como inhibidores de proteinas quinasas
|
|
KR100544347B1
(ko)
|
2003-12-11 |
2006-01-23 |
한국생명공학연구원 |
디아릴이소옥사졸계 화합물을 유효성분으로 함유하는 암 예방 및 치료용 약학적 조성물
|
|
US20050288347A1
(en)
|
2004-03-26 |
2005-12-29 |
Hodge Carl N |
Certain triazole-based compounds, compositions, and uses thereof
|
|
JP5362986B2
(ja)
|
2004-06-23 |
2013-12-11 |
シンタ ファーマスーティカルズ コーポレイション |
癌治療のためのビス（チオ‐ヒドラジドアミド）塩
|
|
WO2006033913A2
(en)
|
2004-09-16 |
2006-03-30 |
Synta Pharmaceuticals Corp. |
Bis (thio-hydrazide amides) for treament of hyperplasia
|
|
JP5204489B2
(ja)
|
2004-11-19 |
2013-06-05 |
シンタ ファーマスーティカルズ コーポレイション |
Ｈｓｐ７０発現を増加するためのビス（チオ‐ヒドラジドアミド）
|
|
US20060167106A1
(en)
|
2004-11-19 |
2006-07-27 |
Mei Zhang |
Compounds acting at the centrosome
|
|
SG164378A1
(en)
|
2005-02-17 |
2010-09-29 |
Synta Pharmaceuticals Corp |
Compounds for the treatment of proliferative disorders
|
|
WO2006113572A1
(en)
|
2005-04-15 |
2006-10-26 |
Synta Pharmaceuticals Corp. |
Methods of increasing natural killer cell activity for therapy
|
|
WO2006113493A2
(en)
|
2005-04-15 |
2006-10-26 |
Synta Pharmaceuticals Corp. |
Methods of determining cancer prognosis via natural killer cell activity
|
|
BRPI0610219A2
(pt)
|
2005-04-15 |
2010-06-08 |
Synta Pharmaceuticals Corp |
métodos de tratamento de um ser humano com cáncer e composição de farmacêutica
|
|
JP2008540658A
(ja)
|
2005-05-16 |
2008-11-20 |
シンタ ファーマシューティカルズ コーポレーション |
ビス（チオ−ヒドラジドアミド）塩の合成
|
|
WO2007021881A1
(en)
|
2005-08-16 |
2007-02-22 |
Synta Pharmaceuticals Corp. |
Bis(thio-hydrazide amide) formulation
|
|
AU2007267847B2
(en)
|
2006-05-25 |
2012-04-12 |
Synta Pharmaceuticals Corp. |
Triazole compounds that modulate Hsp90 activity
|
|
WO2008024298A1
(en)
|
2006-08-21 |
2008-02-28 |
Synta Pharmaceuticals Corp. |
Bis(thiohydrazide amides) for inhibiting angiogenesis
|
|
KR20090045354A
(ko)
|
2006-08-21 |
2009-05-07 |
신타 파마슈티칼스 코프. |
증식성 장애를 치료하기 위한 화합물
|
|
EP2059236A2
(en)
|
2006-08-21 |
2009-05-20 |
Synta Pharmaceuticals Corporation |
Combination with bis(thiohydrazide amides) for treating cancer
|
|
US8497272B2
(en)
|
2006-08-21 |
2013-07-30 |
Synta Pharmaceuticals Corp. |
Compounds for treating proliferative disorders
|
|
JP2010501564A
(ja)
|
2006-08-21 |
2010-01-21 |
シンタ ファーマシューティカルズ コーポレーション |
黒色腫を治療するためのビス（チオヒドラジドアミド）
|
|
WO2008024301A2
(en)
|
2006-08-21 |
2008-02-28 |
Synta Pharmaceuticals Corp. |
Bis(thiohydrazide amides) for use in preventing or delaying the recurrence of melanoma
|
|
AU2007290490B2
(en)
|
2006-08-31 |
2011-09-08 |
Synta Pharmaceuticals Corp. |
Combination with bis(thiohydrazide amides) for treating cancer
|
|
US20080118562A1
(en)
|
2006-09-11 |
2008-05-22 |
Keizo Koya |
Bis(thiohydrazide amides) formulation
|
|
EP2059250A2
(en)
|
2006-09-14 |
2009-05-20 |
Synta Pharmaceuticals Corporation |
Compounds for the treatment of angiogenesis
|
|
TW200829543A
(en)
|
2006-09-15 |
2008-07-16 |
Synta Pharmaceuticals Corp |
Purification of bis(thiohydrazide amides)
|
|
WO2008082579A1
(en)
|
2007-01-03 |
2008-07-10 |
Synta Pharmaceuticals Corp. |
Method for treating cancer
|
|
WO2009020631A2
(en)
|
2007-08-07 |
2009-02-12 |
Synta Pharmaceuticals Corp. |
Compounds for treating proliferative disorders
|
